First Time Loading...

Amedisys Inc
NASDAQ:AMED

Watchlist Manager
Amedisys Inc Logo
Amedisys Inc
NASDAQ:AMED
Watchlist
Price: 94.46 USD -0.52%
Updated: May 17, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement
|
Revenue Breakdown

Balance Sheet

2.1B
+1%
Assets
Growth Rates:
1 Year
+7%
3 Years
+33%
5 Years
+76%
7 Years
+176%
10 Years
+187%
1B
+0.8%
Liabilities
Growth Rates:
1 Year
+15%
3 Years
+28%
5 Years
+51%
7 Years
+265%
10 Years
+175%
1.1B
+2%
Equity
Growth Rates:
1 Year
+1%
3 Years
+38%
5 Years
+109%
7 Years
+126%
10 Years
+200%

Balance Sheet Decomposition
Amedisys Inc

2.1B
Assets
1B
Liabilities
2.1B
Assets
1B
Liabilities
Current Assets 526.4m
Cash & Short-Term Investments 108.2m
Receivables 359.4m
Other Current Assets 58.9m
Non-Current Assets 1.6B
Long-Term Investments 67m
PP&E 131.1m
Intangibles 1.3B
Other Non-Current Assets 18.9m
Current Liabilities 484.9m
Accounts Payable 36.2m
Accrued Liabilities 305.4m
Other Current Liabilities 143.2m
Non-Current Liabilities 516.8m
Long-Term Debt 356.1m
Other Non-Current Liabilities 160.7m

Balance Sheet
Amedisys Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
8
28
30
86
20
30
82
43
41
126
Cash Equivalents
8
28
30
86
20
30
82
43
41
126
Total Receivables
116
125
169
207
193
242
260
287
309
328
Accounts Receivables
101
125
168
203
191
240
260
279
300
320
Other Receivables
15
0
1
3
2
2
0
8
9
8
Other Current Assets
12
23
16
18
11
79
20
27
39
42
Total Current Assets
136
175
215
311
224
351
362
357
389
497
PP&E Net
138
43
37
31
29
113
117
120
119
131
PP&E Gross
138
43
37
31
29
113
117
120
119
131
Accumulated Depreciation
146
142
139
147
96
96
95
97
101
92
Intangible Assets
33
44
47
46
44
65
74
111
101
103
Goodwill
206
262
289
320
330
659
933
1 196
1 287
1 245
Long-Term Investments
30
0
28
26
35
36
14
53
61
66
Other Long-Term Assets
128
158
119
79
55
40
67
20
19
19
Other Assets
206
262
289
320
330
659
933
1 196
1 287
1 245
Total Assets
670
N/A
682
+2%
734
+8%
814
+11%
717
-12%
1 263
+76%
1 567
+24%
1 857
+18%
1 976
+6%
2 060
+4%
Liabilities
Accounts Payable
16
26
30
25
29
31
43
38
44
28
Accrued Liabilities
132
145
146
179
192
286
343
323
296
303
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
12
5
5
11
2
10
11
13
16
36
Other Current Liabilities
2
0
0
0
0
0
60
0
0
106
Total Current Liabilities
162
175
181
215
223
327
456
374
356
474
Long-Term Debt
104
92
88
78
6
232
205
432
419
362
Deferred Income Tax
0
0
0
0
0
0
0
0
20
41
Minority Interest
1
1
1
1
1
1
2
45
55
53
Other Liabilities
5
5
4
4
6
62
96
74
74
64
Total Liabilities
273
N/A
272
0%
274
+1%
298
+9%
236
-21%
622
+164%
758
+22%
926
+22%
925
0%
994
+7%
Equity
Common Stock
0
0
0
0
0
0
0
0
0
0
Retained Earnings
65
68
31
0
120
246
430
639
758
748
Additional Paid In Capital
482
504
538
569
604
645
698
728
755
787
Treasury Stock
20
27
47
54
242
251
319
436
461
469
Other Equity
0
0
0
0
0
0
0
0
0
0
Total Equity
397
N/A
410
+3%
460
+12%
515
+12%
482
-7%
641
+33%
809
+26%
931
+15%
1 052
+13%
1 067
+1%
Total Liabilities & Equity
670
N/A
682
+2%
734
+8%
814
+11%
717
-12%
1 263
+76%
1 567
+24%
1 857
+18%
1 976
+6%
2 060
+4%
Shares Outstanding
Common Shares Outstanding
34
34
34
34
32
32
33
33
33
33

See Also

Summary
AMED intrinsic value, competitors valuation, and company profile.
DCF Valuation
AMED stock valuation using Discount Cash Flow valuation method.
Relative Valuation
AMED stock valuation using valuation multiples.
Wall Street Estimates
AMED price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
AMED stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 138,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.